Characteristics of Pheochromocytoma in a 4‐ to 20‐Year‐Old Population
- 1 August 2006
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1073 (1), 30-37
- https://doi.org/10.1196/annals.1353.003
Abstract
Hypertension in children and adolescents has become a major health problem recently recognized, and in a significant number of patients it is due to an endocrine tumor. The aim of this study was to establish the characteristics of pheochromocytoma in a population of 58 patients between 4 and 20 years of age studied at our Center. They represented a 23% of the total population of 255 pheochromocytoma patients studied. In the younger group (under 20 years of age), there was a marked predominance of severe sustained hypertension (93%), only 7% presented paroxysmal hypertension and none of them was normotensive. The youngsters studied showed a higher incidence of bilateral adrenal pheochromocytoma (34%) and extra-adrenal pheochromocytoma (22%). Malignancy was found in 12% of these patients. In addition, the incidence of familial pheochromocytoma was elevated in these patients (39%). Surprisingly, in contrast with the adult population where the most frequent familial pheochromocytomas were multiple endocrine neoplasia (MEN) type 2A (15%), the younger population showed a higher predominance of von Hippel-Lindau (VHL) (28%) and lower incidence of MEN 2A, MEN 2B, neurofibromatosis (NF), and succinate dehydrogenase subunit B (SDHB). In the VHL group, only two patients belonging to one family, showed the R167W mutation, while the others showed novel mutations in conserved amino acids. It may be speculated that the high incidence of VHL in youngsters may account for the biochemical and clinical features they usually present.Keywords
This publication has 23 references indexed in Scilit:
- Pheochromocytoma in von Hippel–Lindau disease and neurofibromatosis type 1Familial Cancer, 2005
- Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHxFamilial Cancer, 2005
- Mutations of the SDHB and SDHD genesFamilial Cancer, 2005
- SDHC mutations in hereditary paraganglioma/pheochromocytomaFamilial Cancer, 2005
- Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumourJournal of Internal Medicine, 2004
- Pheochromocytoma: State-of-the-Art and Future ProspectsEndocrine Reviews, 2003
- PHEOCHROMOCYTOMA: Special Considerations in ChildrenUrologic Clinics of North America, 2000
- Pheochromocytoma in ChildhoodPublished by Springer Science and Business Media LLC ,1991
- Pheochromocytoma in the pediatric age group: Current statusJournal of Pediatric Surgery, 1983
- Determination of 3-methoxy-4-hydroxymandelic acid in urineClinica Chimica Acta; International Journal of Clinical Chemistry, 1962